US Drug Recall Register
Class II · Moderate risk Terminated Initiated Dec 16, 2022 (4 years ago)

Ganciclovir for Injection, USP, 500mg per vial, packaged in a 10-count carton, Rx Only…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Label mix-up - one vial was mislabeled as Cladribine Injection 10mg/mL inside a 10-count carton of Ganciclovir 500 mg.

What was recalled

Ganciclovir for Injection, USP, 500mg per vial, packaged in a 10-count carton, Rx Only, Mfd. by: THYMOORGAN PHARMAZIE GmbH, Germany, Distributed by Hikma Berkeley Heights, NJ 07922, NDC 0143-9299-01

Recalling firm
Hikma Pharmaceuticals USA Inc.
NDC code
0143-9299-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0090-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Ganciclovir recalls

See all